Review: Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures

Human Reproduction

Volumn 7, Issue 3, 1992, Pages 320-327

  Rizk, B ^a   Smitz, J ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

GnRH agonists; In vitro fertilization; Ovarian hyperstimulation syndrome; Ovarian stimulation; Polycystic ovary disease

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE;

DISEASE PREDISPOSITION; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; IATROGENIC DISEASE; LUTEAL PHASE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PATIENT MONITORING; PREGNANCY RATE; REVIEW; RISK FACTOR; SUPEROVULATION; ULTRASOUND;

ANIMAL; FEMALE; FERTILIZATION IN VITRO; GONADORELIN; HUMAN; MENOTROPINS; OVARIAN HYPERSTIMULATION SYNDROME; POLYCYSTIC OVARY SYNDROME;

EID: 0026598213     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a137642     Document Type: Review

References (64)

1. Aboulghar, M. A., Mansour, R. T., Serour, G. I., Amin, Y. and Rizk, P. (1991) The impact of follicular aspiration and luteal phase support on the incidence of ovarian hyperstimulation syndrome. Presented at the VII World Congress on IVF and Assisted Procreation, Paris, France. Hum. Reprod., 6 (Suppl. 1), Abstr. P38, p. 174.
2. Adams, J., Robson, J. W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J., 293, 355-358.
3. Amso, N. N., Ahuja, K. K., Morris, N. and Shaw, R. W. (1990) The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos. Fenil. Steril., 53, 1087-1090.
4. Belaisch-Allart, J. and De Mouzon, J. (1989) The effect of luteal phase supplementation with hCG after ovulation stimulation using a LHRH/HMG analogue in in-vitro fertilization programmes. Contracept. Fenil. Sexual., 17, 747-748.
5. Belaisch-Allart, J., De Mouzon, J., Lapouterle, C. and Mayer, M. (1990) The effect of HCG supplementation after combined GnRH agonist/HMG treatment in IVF programmes. Hum. Reprod., 5, 163-166.
6. Bilan FIVNAT (1989) Réponses aux stimulations de l’ovulation dans les procréations médicalement assistées (PMA). Contracept. Fenil. Sexual., 18, 592-594.
7. Blankstein, J., Saadon, T., Shalev, K., Kukia, E., Rabinovici, J., Pariente, C., Lunenfeld, B., Serr, D. and Mashiach, S. (1987) Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory follicles. Fenil. Steril., 47, 597-602.
8. Buvat, J., Buvat-Herbaut, M., Marcolin, G., Dehaene, J. L., Verbecq, P. and Renouard, O. (1989) Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fenil. Steril., 52, 553-559.
9. Buvat, J., Marcolin, G., Guittard, C., Herbaut, J. C., Louvet, A. L. and Dehaene, J. L. (1990) Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone. Fenil. Steril., 53, 490-494.
10. Charbonnel, B., Krempf, M., Blanchar, P., Dano, F. and Delage, C. (1987) Induction of ovulation in polycystic ovary syndrome with a combination of luteinizing hormone-releasing hormone analog and exogenous gonadotropins. Fenil. Steril., 47, 920-924.
11. Check, J. H., Wu, C. H., Gocial, B. G. and Adelson, H. G. (1985) Severe ovarian hyperstimulation syndrome from treatment with urinary follicle-stimulating hormone: two cases. Fenil. Steril., 42, 317-320.
12. Culler, M. D., Tarlatzis, B., Lightman, A., Fernandez, L. A., Dechemey, A. H., Negro-Villar, A. and Naftolin, F. (1986) Angiotensin II-like immunoreactivity in human ovarian follicular fluid. J. Clin. Endocrinol. Metab., 62, 613-615.
13. Emperaire, J. -C. and Ruffle, A. (1991) Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome. Fenil. Steril., 65, 506-510.
14. Fernandez, L. A., Tarlatzis, B. C., Rzasa, P. J., Caride, V. J., Laufer, N., Negro-Vilar, A. F., DeCherney, A. H. and Naftolin, F. (1985) Reninlike activity in ovarian follicular fluid. Fenil. Steril., 44, 219-223.
15. Fleming, R., Haxton, M. J., Hamilton, M. P. R., McCune, G. S., Black, W. P., MacNaughton, M. C. and Coutts, J. R. T. (1985a) Successful treatment of infertile women with digomenorrhoea using a combination of a LHRH agonist and exogenous gonadotrophins. Br. J. Obstet. Gynaecol., 92, 369-374.
16. Fleming, R., Black, W. P. and Coutts, J. R. T. (1985b) Effects of LH suppression in polycystic ovary syndrome. Clin. Endocrinol., 23, 683-688.
17. Forman, R. G., Frydman, R., Egan, D., Ross, C. and Barlow, D. (1990) Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention. Fenil. Steril., 53, 502-509.
18. Frederick, J. L., Shimanuki, T. and DiZerega, G. S. (1984) Initiation of angiogenesis by human follicular fluid. Science, 224, 389-390.
19. Golan, A., Ron-El, A., Herman, A., Soffer, Y., Weinraub, Z. and Caspi, E. (1989) Ovarian hyperstimulation syndrome: an update review. Obstet. Gynecol. Surv., 44, 430-440.
20. Gonen, Y., Balakier, H., Powell, W. and Casper, R. (1990) Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J. Clin. Endocrinol. Metab., 71, 918-922.
21. Haning, R. V., Austin, C. W., Carlson, I. H., Kuzma, D. L., Shapiro, S. S. and Zweibel, W. J. (1983) Plasma estradiol is superior to ultrasound and urinary estriol glucuromde as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fenil. Steril., 40, 31-36.
22. Herman, A., Ron-El, R., Golan, A., Raziel, A., Soffler, Y. and Caspi, E. (1990) Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotrophin in in-vitro fertilization stimulated with gonadotrophin-releasing hormone analog and menotropins. Fenil. Steril., 53, 92-96.
23. Hirshfield, A. N. (1989) Rescue of atretic follicles in vitro and in vivo. Biol. Reprod., 40, 181-190.
24. Itskovitz, J., Boldes, R., Levron, J., Erlik, Y., Kahana, L. and Brandes, J. (1991) Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropinreleasing hormone agonist. Fenil. Steril., 56, 213-220.
25. Kaaja, R., Siegberg, R., Tntinen, A. and Koskimies, A. (1989) Severe ovarian hyperstimulation syndrome and deep venous thrombosis. Lancet, 2, 1043.
26. Lanzone, A., Fulghesu, A. M., Spina, M. A., Apa, R., Menini, E., Caruso, A. and Mancuso, S. (1987) Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 65. 1253-1258.
27. Lunenfeld, B. and Insler, V. (1978) Gonadotrophins. In Diagnosis and Treatment of Functional Infertility. Grosse Verlag, Berlin, pp. 61-69.
28. Morreau, L., Arbogast, E., Ménard, A. and Dellenbach, P. (1989) Ovaires polykystiques et réponses ovariennes multifolliculaires: les limites de la fécondation in vitro. Contracept. Fertil. Sexual., 17, 433-435.
29. Muller, P. (1962) Gonadotrophines en Gynécologie. In Beclere, C. (ed.), Masson, Paris, p. 137.
30. Navot, D., Margalioth, E. J., Laufer, N., Birkenfeld, A., Relou, A, Rosier, A. and Schenker, J. G. (1987) Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil. Steril., 48, 57-61.
31. Pellicer, A., Ruiz, A., Castellvi, R. M., Calatayud, C., Ruiz, M., Tarin, J. J., Miro, F. and Bonilla-Musoles, F. (1989) Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophinreleasing hormone analogues (GnRH-a) and gonadotrophins? Hum. Reprod., 4, 536-540.
32. Pellicer, A., Miro, F., Sampaia, M., Gomez, E. and Bonilla-Musoles, F. M. (1991) In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17, 20-desmolase deficiency. Fertil. Steril., 55. 970-975.
33. Polishuk, W. K. and Schenker, J. G. (1969) Ovarian overstimulation syndrome. Fertil. Steril., 20, 443-450.
34. Pride, S. M., Ho Yuen, B., Moon, Y. S. and Leung, P. C. S. (1986) Relationship of GnRH, danazol and prostaglandin blockade to ovarian enlargement and ascites formation of the ovarian hyperstimulation syndrome in the rabbit. Am. J. Obstet. Gynecol., 154, 1155-1160.
35. Pride, S. M., James, C. and Yuen, B. (1990) The ovarian hyperstimulation syndrome. Semin. Reprod. Med., 8, 247-259.
36. Rabau, E., David, A., Serr, D. M., Mashiach, S. and Lunenfeld, B. (1967) Human menopausal gonadotropins for anovulation and sterility: results of 7 years of treatment. Am. J. Obstet. Gynecol., 98, 92-98.
37. Rabinovici, J., Kushir, O., Shalev, J., Goldenberg, M. and Blankstein, J. (1987) Rescue of menotropin cycles prove to develop ovarian hyperstimulation. Br. J. Obstet. Gynaecol., 94, 1098-1102.
38. Rainhom, J. D., Forman, R. G., Belaisch-Allart, J., Hazout, A., Fries, N., Testait, J. and Frydman, R. (1987) One year’s experience with programmed oocyte retrieval. Hum. Reprod., 2, 491-494.
39. Raj, S. G., Berger, M. J., Grimes, E. M. and Taymor (1977) The use of gonadotrophins for the induction of ovulation in women with polycystic ovarian disease. Fertil. Steril., 28. 1280-1284.
40. Rizk, B. (1992) Ovarian hyperstimulation syndrome. In Brinsden, P. R and Rainsbury, P. A. (eds), The Bourn Hall Textbook of In Vitro Fertilization and Assisted Conception, Chapter 23. Parthenon Publishing. UK, in press.
41. Rizk, B. and Aboulghar, M. A. (1991) Modem management of ovarian hyperstimulation syndrome. Hum. Reprod., 6, 1082-1087.
42. Rizk, B., Meagher, S. and Fisher, A. M. (1990) Severe ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum. Reprod., 5, 697-698.
43. Rizk, B., Aboulghar, M. A., Mansour, R. T., Serour, G. I. and Amin, Y. (1991a) Severe ovarian hyperstimulation syndrome, analytical study of twenty-one cases. Presented at the VO World Congress on In Vitro Fertilization and Assisted Procreation. Paris. France. Hum. Reprod., 6 (Suppl. 1), Abstr. P557, pp. 368-369.
44. Rizk, B., Lenton, W., Vere, M., Martin, R. and Latarche. E. (1991b) The use of gonadotrophin releasing hormone agonist in a programmedoocyte retrieval for GIFT. Presented at the VII World Congress on In Vitro Fertilization and Assisted Procreation. Paris, France. Hum. Reprod., 6, (Suppl. 1), Abstr. P556, pp. 368-369.
45. Salat-Baroux, J., Tibi, G., Alvarez, S., Comet, D., Antoine, J. M. and Gomes, A. (1989) Ultrasonographic prediction of ovarian hyperstimulation after IVF. Abstracts of the VI World Congress on In Vitro Fertilisation and Alternate Assisted Reproduction, Jerusalem, Israel, April 2-7, p. 27.
46. Schenker, I. G. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril., 30, 255-268.
47. Seibel, M. M., Kamrava, M. M., McArdle, C. and Taymor, M. L. (1984) Treatment of polycystic ovarian disease with chronic low-dose follicle stimulating hormone; biochemical changes and ultrasound correlation. Int. J. Fertil., 43, 703-707.
48. Seibel, M., McArdle, C., Smith, D. and Taymor, M. L. (1985) Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin. Fertil. Steril., 43, 703-708.
49. Smith, E. M., Anthony, F. W., Gadd, S. C. and Masson, G. M. (1989) Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in-vitro fertilisation programme. Br. Med. J., 298, 1483-1486.
50. Smitz, J., Devroey, P., Braeckmans, P., Camus, M., Khan, I., Staessen, C., Van Waesberghe, L., Wisanto, A. and Van Steirteghem, A. C. (1987) Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Hum. Reprod., 2, 309-314.
51. Smitz, J., Devroey, P., Camus, M., Deschacht, J., Khan, I., Staessen, C., Van Waesberghe, L., Wisanto, A. and Van Steirteghem, A. C. (1988a) The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF and GIFT. Hum. Reprod., 3, 585
52. Smitz, J., Devroey, P., Bourgain, C., Camus, M., Van Waesberghe, L., Wisanto, A. and Van Steirteghem, A. C. (1988b) Luteal supplementation regimens after combined GnRH agonist HMG superovulation. Abstract no. 31. J. Reprod. Fertil. (Abst. Ser.), 2, 18.
53. Smitz, J., Van den Abbeel, E., Staessen, C., Khan, I., Devroey, P. and Van Steirteghem, A. C. (1989) Number of oocytes retrieved and outcome of IVF after GnRH agonist/HMG superovulation. Proceedings of the 45th Annual Meeting of the AFS San Francisco, 11-16 November 1989, Abstract no. S117, p. 139. American Fertility Society, Washington, DC.
54. Smitz, J., Camus, M., Devroey, P., Erard, P., Wisanto, A. and Van Steirteghem, A. C. (1990) Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum. Reprod., 5, 933-937.
55. Tarin, J. J. and Pellicer, A. (1990) Consequences of high ovarian response to gonadotropins: a cytogenetic analysis of unfertilized human oocytes. Fertil. Steril., 54, 665-670.
56. Testait, J. (1990) Relation entre folliculogenèse induite et qualité de l’ovocyte et de l’embryon. Contracept. Fertil. Sexual., 18, 755-762.
57. Testait, J., Forman, R., Belaisch-AUart, J., Volante, M., Hazout, A., Strubb, N. and Frydman, R. (1989a) Embryo quality and uterine receptivity in in-vitro fertilization cycles with and without agonists of gonadotrophin releasing hormone. Hum. Reprod., 4, 198-201.
58. Testait, J., Belaisch-Allart, J., Forman, R., Gazengel, A., Strubb, N., Hazout, A. and Frydman, R. (1989b) Influence of different stimulation treatments on oocyte characteristics and in vitro fertilizing ability. Hum. Reprod., 4, 192-197.
59. Thaler, I., Yoffe, N., Kaftory, J. and Brandes, J. (1981) Treatment of ovarian hyperstimulation syndrome: the physiological basis for a modified approach. Fertil. Steril., 36, 110-113.
60. Tulandi, T., Mclnnes, R. A. and Arronet, G. H. (1984) Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin. Int. J. Fertil., 29, 113-117.
61. Tummon, I. S., Henig, I., Radwanska, E., Binor, Z., Rawlins, R. and Dmowski, W. P. (1988) Persistent ovarian cysts following administration of human menopausal and chorionic gonadotrophins: an attenuated form of ovarian hyperstimulation syndrome. Fertil. Steril., 49, 244-248.
62. Tyler, E. (1968) Treatment of anovulation with menotropins. J. Am. Med. Assoc., 205, 16-22.
63. Van Steirteghem, A. C., Van den Abbeel, E., Smitz, J., Camus, M., Khan, l., Staessen, C. and Devroey, P. (1989) Cryopreservation of supernumerary embryos after GIFT and IVF in clomid-HMG and Buserelin-HMG stimulated cycles. Abstracts of VI World Congress on In-vitro Fertilization and Alternative Assisted Reproduction, Jerusalem, April 2-7, p. 52. Published by Serono.
64. Yen, S. S. C. (1980) The polycystic ovary syndrome. Clin. Endocrinol., 12, 177-208.